Enovix (NASDAQ:ENVX – Get Free Report) was downgraded by Wall Street Zen from a “hold” rating to a “sell” rating in a research report issued to clients and investors on Saturday.
Several other research firms have also commented on ENVX. Cowen restated a “hold” rating on shares of Enovix in a research report on Tuesday, July 8th. Benchmark increased their target price on shares of Enovix from $15.00 to $25.00 and gave the company a “buy” rating in a research report on Friday, July 25th. Craig Hallum reiterated a “buy” rating and issued a $15.00 target price (up previously from $12.00) on shares of Enovix in a research report on Tuesday, July 8th. TD Cowen upgraded shares of Enovix to a “hold” rating and increased their target price for the company from $7.00 to $15.00 in a research report on Monday, July 7th. Finally, Canaccord Genuity Group increased their target price on shares of Enovix from $20.00 to $22.00 and gave the company a “buy” rating in a research report on Monday, August 4th. Five investment analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $17.00.
Check Out Our Latest Report on Enovix
Enovix Stock Up 1.9%
Enovix (NASDAQ:ENVX – Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The company reported ($0.13) EPS for the quarter, topping the consensus estimate of ($0.15) by $0.02. The business had revenue of $7.50 million during the quarter, compared to analyst estimates of $5.48 million. Enovix had a negative net margin of 481.35% and a negative return on equity of 73.88%. The company’s quarterly revenue was up 98.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned ($0.14) earnings per share. Enovix has set its Q3 2025 guidance at -0.180–0.140 EPS. As a group, equities analysts expect that Enovix will post -1.01 earnings per share for the current year.
Enovix announced that its Board of Directors has authorized a share buyback plan on Wednesday, July 2nd that allows the company to repurchase $60.00 million in shares. This repurchase authorization allows the company to repurchase up to 3.1% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s management believes its shares are undervalued.
Institutional Investors Weigh In On Enovix
A number of institutional investors and hedge funds have recently bought and sold shares of the business. Franklin Resources Inc. lifted its holdings in Enovix by 1.1% in the 2nd quarter. Franklin Resources Inc. now owns 96,239 shares of the company’s stock valued at $995,000 after acquiring an additional 1,093 shares during the last quarter. tru Independence LLC lifted its holdings in Enovix by 0.4% in the 2nd quarter. tru Independence LLC now owns 295,690 shares of the company’s stock valued at $3,057,000 after acquiring an additional 1,155 shares during the last quarter. Intellectus Partners LLC lifted its holdings in Enovix by 1.2% in the 2nd quarter. Intellectus Partners LLC now owns 103,522 shares of the company’s stock valued at $1,070,000 after acquiring an additional 1,200 shares during the last quarter. Wealth Enhancement Advisory Services LLC lifted its holdings in Enovix by 6.7% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 21,413 shares of the company’s stock valued at $233,000 after acquiring an additional 1,336 shares during the last quarter. Finally, Teacher Retirement System of Texas lifted its holdings in Enovix by 5.7% in the 2nd quarter. Teacher Retirement System of Texas now owns 24,606 shares of the company’s stock valued at $254,000 after acquiring an additional 1,336 shares during the last quarter. 50.92% of the stock is owned by institutional investors and hedge funds.
About Enovix
Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Featured Stories
- Five stocks we like better than Enovix
- How to start investing in penny stocks
- Why DocuSign Could Be a SaaS Value Play After Q2 Earnings
- Canada Bond Market Holiday: How to Invest and Trade
- Lululemon Share Price Has Plenty of Room Left to Fall
- How to Profit From Value Investing
- Advanced Micro Devices’ 2026 Forecasts Are Way Too Low
Receive News & Ratings for Enovix Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Enovix and related companies with MarketBeat.com's FREE daily email newsletter.